Incidence and time trends of drug-induced parkinsonism: A 30-year population-based study
- PMID: 27779780
- PMCID: PMC5318251
- DOI: 10.1002/mds.26839
Incidence and time trends of drug-induced parkinsonism: A 30-year population-based study
Abstract
Background: Epidemiological studies of drug-induced parkinsonism remain limited.
Objectives: To investigate the incidence and time trends of drug-induced parkinsonism over 30 years in a geographically defined American population.
Methods: We used the medical records-linkage system of the Rochester Epidemiology Project to identify all persons in Olmsted County, Minnesota, who received a screening diagnostic code for parkinsonism from 1976 through 2005. A movement disorders specialist reviewed the complete medical records of each person to confirm the presence of drug-induced parkinsonism associated with dopamine-blocking or dopamine-depleting medications.
Results: Among 906 incident cases of parkinsonism from 1976 to 2005, 108 persons had drug-induced parkinsonism (11.9%). The average annual incidence rate of drug-induced parkinsonism was 3.3 per 100,000 person-years, was higher in women, and increased with older age. Drug-induced parkinsonism was the fifth-most common type of parkinsonism overall; however, it was the most common type among persons younger than age 40 years. Typical antipsychotic drugs were the most common class of drugs associated with parkinsonism, whereas atypical antipsychotic drugs were rarely involved. The incidence rate of drug-induced parkinsonism decreased 32.0% per decade (relative risk = 0.68; 95% confidence interval: 0.49-0.94) and 68.6% over the 30 years of the study. The decrease was similar in men (65.2%) and women (69.4%); however, the trend was significant only in women.
Conclusions: The incidence of drug-induced parkinsonism increased with older age and was higher in women at all ages. Typical antipsychotic drugs were the most common cause. The incidence of drug-induced parkinsonism decreased over the 30 years of the study because of changes in drug use. © 2016 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
Keywords: drug-induced parkinsonism; incidence; parkinsonism; sex differences; time trends.
© 2016 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
Figures



Comment in
-
Response to Letter by Friedman on "Incidence and time trends of drug-induced parkinsonism: A 30-year population-based study".Mov Disord. 2017 Jul;32(7):1111-1112. doi: 10.1002/mds.27051. Epub 2017 Jun 14. Mov Disord. 2017. PMID: 28612941 Free PMC article. No abstract available.
-
Drug-induced parkinsonism.Mov Disord. 2017 Jul;32(7):1111. doi: 10.1002/mds.27050. Epub 2017 Jun 14. Mov Disord. 2017. PMID: 28612949 No abstract available.
Similar articles
-
Time Trends in the Incidence of Parkinson Disease.JAMA Neurol. 2016 Aug 1;73(8):981-9. doi: 10.1001/jamaneurol.2016.0947. JAMA Neurol. 2016. PMID: 27323276 Free PMC article.
-
Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990.Neurology. 1999 Apr 12;52(6):1214-20. doi: 10.1212/wnl.52.6.1214. Neurology. 1999. PMID: 10214746
-
Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism.JAMA Neurol. 2013 Jul;70(7):859-66. doi: 10.1001/jamaneurol.2013.114. JAMA Neurol. 2013. PMID: 23689920 Free PMC article.
-
Managing antipsychotic-induced parkinsonism.Drug Saf. 1999 Mar;20(3):269-75. doi: 10.2165/00002018-199920030-00006. Drug Saf. 1999. PMID: 10221855 Review.
-
Drug-induced parkinsonism in the aged. Recognition and prevention.Drugs Aging. 1994 Aug;5(2):127-32. doi: 10.2165/00002512-199405020-00006. Drugs Aging. 1994. PMID: 7981484 Review.
Cited by
-
Subcortical structure alteration in patients with drug-induced parkinsonism: Evidence from neuroimaging.IBRO Neurosci Rep. 2024 Mar 6;16:436-442. doi: 10.1016/j.ibneur.2024.03.001. eCollection 2024 Jun. IBRO Neurosci Rep. 2024. PMID: 38510074 Free PMC article.
-
Exploring cognitive and emotional symptoms associated with hippocampal subfield atrophy in drug-induced Parkinsonism.Front Aging Neurosci. 2025 Jul 9;17:1566785. doi: 10.3389/fnagi.2025.1566785. eCollection 2025. Front Aging Neurosci. 2025. PMID: 40703680 Free PMC article.
-
Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia-Key Differences in Pathophysiology and Clinical Management.Neurol Ther. 2018 Dec;7(2):233-248. doi: 10.1007/s40120-018-0105-0. Epub 2018 Jul 19. Neurol Ther. 2018. PMID: 30027457 Free PMC article. Review.
-
Prospective Five-Year Follow-Up of Patients with Schizophrenia Suspected with Parkinson's Disease.Parkinsons Dis. 2022 May 26;2022:2727515. doi: 10.1155/2022/2727515. eCollection 2022. Parkinsons Dis. 2022. PMID: 35698464 Free PMC article.
-
Probable progressive supranuclear palsy in a patient with chronic schizophrenia: A case report.Exp Ther Med. 2022 Jun 1;24(1):484. doi: 10.3892/etm.2022.11411. eCollection 2022 Jul. Exp Ther Med. 2022. PMID: 35761809 Free PMC article.
References
-
- Williams DR. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule‐associated protein tau. Intern Med J 2006;36:652–660. - PubMed
-
- Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease‐related pathology. Cell Tissue Res 2004;318:121–134. - PubMed
-
- Thanvi B, Treadwell S. Drug induced parkinsonism: a common cause of parkinsonism in older people. Postgrad Med J 2009;85:322–326. - PubMed
-
- Rochon PA, Stukel TA, Sykora K, et al. Atypical antipsychotics and parkinsonism. Arch Intern Med 2005;165:1882–1888. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources